vTv Therapeutics develops oral medicines for metabolic and inflammatory diseases, led by a treatment being tested for type 1 diabetes. It last closed at $16.87 on Nov 17, down 4.64% on the day.
VTVT · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 37% below its 20 day and 62% below its 50 day average. It is 94% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 17), oversold. The nearest support is the 52 week low at $16.71, and the nearest resistance the Pivot at $17.19.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 8.6%/day
Key levels
$44.0052 week high+160.8%
$32.69200 day average+93.8%
$30.18100 day average+78.9%
$27.4050 day average+62.4%
$27.01Swing high (Oct 29)+60.1%
$23.1020 day average+36.9%
$17.66Pivot R1+4.7%
$17.19Pivot+1.9%
$16.87Last close
$16.7152 week low−0.9%
$16.39Pivot S1−2.8%
Indicators
RSI (14)
17.37
Oversold below 30
Oversold
MACD
-2.67
Below its signal line
Bearish
Stochastic
3.5
Near the bottom of its range
Oversold
ADX (14)
35.5
Trending down
Williams %R
-98.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-153.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−28.4%
Change over 10 sessions
Bearish
ATR (14)
$1.45
Typical daily range, 8.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Turning down, oversold
Short trendBearish
Long trendNeutral
MomentumWeak
StretchOversold
VolatilityNormal, 23.6%/day
Key levels
$44.0052 week high+160.8%
$32.69200 day average+93.8%
$30.18100 day average+78.9%
$27.4050 day average+62.4%
$27.01Swing high (Oct 29)+60.1%
$23.1020 day average+36.9%
$17.66Pivot R1+4.7%
$17.19Pivot+1.9%
$16.87Last close
$16.7152 week low−0.9%
$16.39Pivot S1−2.8%
Indicators
RSI (14)
26.40
Oversold below 30
Oversold
MACD
-3.25
Below its signal line
Bearish
Stochastic
1.8
Near the bottom of its range
Oversold
ADX (14)
22.8
Weak trend
Williams %R
-99.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-216.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−47.2%
Change over 10 sessions
Bearish
ATR (14)
$3.98
Typical daily range, 23.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VTVT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VTVT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow VTVT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How VTVT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VTVT is in one of them and how their past VTVT trades turned out.
vTv Therapeutics is a biopharmaceutical company based in High Point, North Carolina. It develops oral medicines for metabolic and inflammatory diseases. Its main product candidate, cadisegliatin, is being tested as a medicine taken by mouth alongside insulin for people with type 1 diabetes, a condition in which the body stops producing insulin. The company also works with partners on its other drug candidates.